Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1
Clinical trial NCT04455503 · TERMINATED
Trial details
- NCT number
- NCT04455503
- Sponsor
- Evaxion Biotech A/S
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2023-02-28
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.